We are live on
!
Find out more
Pacira BioSciences
PCRX
PCRX
192 hedge funds and large institutions have $1.87B invested in Pacira BioSciences in 2017 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 60 increasing their positions, 61 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 36
44% more capital invested
Capital invested by funds: $1.3B → $1.87B (+$573M)
35% more call options, than puts
Call options by funds: $26.7M | Put options by funds: $19.8M
5% more funds holding
Funds holding: 182 → 192 (+10)
1.85% more ownership
Funds ownership: 107.68% → 109.53% (+1.9%)
2% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 61
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
192
Holders Change
+10
Holders Change %
+5.49%
% of All Funds
4.78%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
54
Increased
60
Reduced
61
Closed
36
Calls
$26.7M
Puts
$19.8M
Net Calls
+$6.9M
Net Calls Change
+$5.67M
Top Buyers
| 1 |
BlackRock
New York
|
+$137M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$37.6M |
| 3 |
CCM
Cadian Capital Management
New York
|
+$26.6M |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$21.7M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$20.2M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$39.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.9M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$21.8M |
| 4 |
HM
HealthCor Management
New York
|
-$20.5M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$16.4M |
